Publication | Closed Access

High Ki-67 score is indicative of a greater benefit from adjuvant chemotherapy when added to endocrine therapy in Luminal B HER2 negative and node-positive breast cancer

Node-positive Breast CancerEndocrine OncologyBreast OncologyHigh Ki-67 ScoreMedicineImmunologyAdjuvant ChemotherapyPathologyBreast CancerCancer TreatmentOncologyEndocrine-related Cancer